https://www.clinicaltrialsarena.com/news/fda-grants-trascenta-clearance-for-phase-iii-trial-of-osemitamab/
FDA grants Trascenta clearance for Phase III trial of Osemitamab
Oct 6, 2023 - Osemitamab is advancing towards becoming a global gastric cancer therapy with its progression to Phase III clinical trials in the US.
phase iiifdagrantsclearancetrial